New England Research & Management’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$910K	Buy	1,680 +550	+49%	+$310K	0.35%	76
2026 Q1	$670K	Sell	1,130 -3,310	-75%	-$1.65M	0.28%	93
2025 Q4	$2.16M	Hold	4,440	–	–	0.95%	35
2025 Q3	$1.86M	Sell	4,440 -1,085	-20%	-$365K	0.85%	35
2025 Q2	$1.59M	Sell	5,525 -125	-2%	-$37.4K	0.75%	40
2025 Q1	$1.74M	Buy	5,650 +10	+0.2%	+$3.43K	0.88%	34
2024 Q4	$1.99M	Sell	5,640 -2,080	-27%	-$765K	1.01%	28
2024 Q3	$2.77M	Sell	7,720 -475	-6%	-$160K	1.3%	17
2024 Q2	$2.61M	Sell	8,195 -2,235	-21%	-$592K	1.25%	16
2024 Q1	$2.4M	Buy	10,430 +2,395	+30%	+$540K	1.18%	24
2023 Q4	$1.77M	Sell	8,035 -470	-6%	-$108K	0.94%	31
2023 Q3	$1.92M	Buy	8,505 +2,225	+35%	+$512K	1.09%	24
2023 Q2	$1.39M	Buy	6,280 +715	+13%	+$158K	0.8%	48
2023 Q1	$1.25M	Buy	5,565 +1,115	+25%	+$275K	0.73%	49
2022 Q4	$1.24M	Sell	4,450 -1,100	-20%	-$278K	0.71%	46
2022 Q3	$1.16M	Buy	+5,550	New	+$1.24M	0.73%	45
2022 Q1	–	Sell	-4,675	Closed	-$1.01M	–	197
2021 Q4	$1.01M	Sell	4,675 -775	-14%	-$152K	0.49%	66
2021 Q3	$1.01M	Buy	5,450 +4,325	+384%	+$852K	0.53%	67
2021 Q2	$202K	Sell	1,125 -2,125	-65%	-$405K	0.1%	169
2021 Q1	$544K	Buy	+3,250	New	+$542K	0.3%	101

Other funds holding UTHR